Literature DB >> 19869922

SWINE INFLUENZA : I. EXPERIMENTAL TRANSMISSION AND PATHOLOGY.

R E Shope1.   

Abstract

Swine influenza has been induced in pigs by the intranasal instillation of material from spontaneous cases of the disease as occurring epizootically in eastern Iowa. The experimental disease has the same features as the epizootic. It has been maintained for study by serial passages accomplished either by intranasal instillation or by pen contact. Eight strains of the virus have been established experimentally during three epizootic periods. The clinical disease induced by these eight strains has been in general the same although its severity and mortality have varied. The principal features of the pathology of swine influenza are an exudative bronchitis accompanied by marked damage of the bronchial epithelium and its cilia, a peribronchial round cell infiltration, and massive pulmonary atelectasis. The latter is modified somewhat by a round cell infiltration of the alveolar walls. The lymph nodes, especially the cervical and mediastinal ones, are hyperplastic and edematous. There is usually a mild to moderate, acute splenic tumor. The mucosa of the stomach and colon is congested. The pneumonia following swine influenza is, characteristically, lobular in type and of the same general distribution as the atelectasis. The non-pneumonic areas of lung are extremely edematous and congested.

Entities:  

Year:  1931        PMID: 19869922      PMCID: PMC2131998          DOI: 10.1084/jem.54.3.349

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  68 in total

1.  H1N1 infection associated with persistent lower respiratory tract illness in an infant with isolated IgA deficiency.

Authors:  Ankur Priyadarsi; Jhuma Sankar
Journal:  BMJ Case Rep       Date:  2012-02-21

2.  INFLUENZA VIRUSES IN CELL CULTURES. II. USE OF CALF KIDNEY CELLS FOR QUANTAL ASSAY.

Authors:  F LEHMANN-GRUBE
Journal:  Arch Gesamte Virusforsch       Date:  1964

3.  INFLUENZA VIRUSES IN CELL CULTURES. I. PREPARATION AND USE OF FETAL PIG LUNG CELLS FOR QUANTAL ASSAY.

Authors:  F LEHMANN-GRUBE
Journal:  Arch Gesamte Virusforsch       Date:  1963-10-07

4.  A Paper on TISSUE CHANGES IN VIRUS DISEASES.

Authors:  J C Ledingham
Journal:  Br Med J       Date:  1932-11-26

Review 5.  Influenza: the once and future pandemic.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Public Health Rep       Date:  2010-04       Impact factor: 2.792

6.  Mutations during the Adaptation of H9N2 Avian Influenza Virus to the Respiratory Epithelium of Pigs Enhance Sialic Acid Binding Activity and Virulence in Mice.

Authors:  W Yang; D Punyadarsaniya; R L O Lambertz; D C C Lee; C H Liang; D Höper; S R Leist; A Hernández-Cáceres; J Stech; M Beer; C Y Wu; C H Wong; K Schughart; F Meng; G Herrler
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

7.  The new influenza A H1N1 virus: balancing on the interface of humans and animals.

Authors:  Frank J U M van der Meer; Karin Orsel; Herman W Barkema
Journal:  Can Vet J       Date:  2010-01       Impact factor: 1.008

8.  Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses.

Authors:  Eleca J Dunham; Vivien G Dugan; Emilee K Kaser; Sarah E Perkins; Ian H Brown; Edward C Holmes; Jeffery K Taubenberger
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Characterization of a 1980-swine recombinant influenza virus possessing H1 hemagglutinin and N2 neuraminidase similar to that of the earliest Hong Kong (H3N2) virus.

Authors:  K Nerome; Y Yoshioka; S Sakamoto; H Yasuhara; A Oya
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.

Authors:  Gavin J D Smith; Dhanasekaran Vijaykrishna; Justin Bahl; Samantha J Lycett; Michael Worobey; Oliver G Pybus; Siu Kit Ma; Chung Lam Cheung; Jayna Raghwani; Samir Bhatt; J S Malik Peiris; Yi Guan; Andrew Rambaut
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.